Walleye Capital’s Tyra Biosciences TYRA Stock Holding History

Walleye Capital’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$717K	Buy	+18,715	New	+$606K	﹤0.01%	2371
2025 Q4	–	Sell	-297,808	Closed	-$4.17M	–	5162
2025 Q3	$4.17M	Sell	297,808 -72,600	-20%	-$828K	0.02%	1041
2025 Q2	$3.54M	Buy	370,408 +229,666	+163%	+$2.18M	0.01%	1104
2025 Q1	$1.31M	Buy	140,742 +77,762	+123%	+$1.01M	0.01%	1757
2024 Q4	$875K	Sell	62,980 -63,617	-50%	-$1.15M	﹤0.01%	2496
2024 Q3	$2.98M	Buy	126,597 +95,451	+306%	+$2M	0.01%	1592
2024 Q2	$498K	Buy	31,146 +14,259	+84%	+$245K	﹤0.01%	3522
2024 Q1	$277K	Buy	+16,887	New	+$277K	﹤0.01%	3721

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

APMC

Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Walleye Capital's TYRA Position: Q1 2026 in Review

Walleye Capital opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 18,715 shares worth $717K. The stake represents ﹤0.01% of the portfolio and ranks #2371 among its holdings. This is a return to the name: Walleye Capital previously reported a position in TYRA as recently as Q3 2025.

Walleye Capital first reported a position in TYRA in Q1 2024 and has held it in 8 quarters since. The position peaked at $4.17M in Q3 2025. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

Walleye Capital held 18,715 shares of Tyra Biosciences worth $717K as of Q1 2026.
Tyra Biosciences was a new Walleye Capital position in Q1 2026.
Tyra Biosciences made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #2371 holding.
Walleye Capital first reported a position in Tyra Biosciences in Q1 2024 and has held it in 8 quarters since.
Walleye Capital's Tyra Biosciences position peaked at $4.17M in Q3 2025.
164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.